0 likes | 2 Views
The Glutethimide Market was valued at over USD 12.8 million in 2024 and is projected to reach USD 19 million by 2034, growing at a CAGR of 4.4% during the forecast period (2025u20132034). This growth is primarily driven by the rising incidence of neurological disorders, increasing demand for sedative-hypnotic treatments, and advancements in drug formulations enhancing therapeutic outcomes.
E N D